Real-World Clinical Data and Cohort Design

Building on the foundational concepts introduced in a prior webinar, this follow-up session will focus on how multimodal real-world clinical data can be used to define and investigate research cohorts.

Join this webinar to explore how layering multiple types of clinical data can improve cohort precision and research insight.

Using examples of de-identified data sourced from a large academic medical center, the featured speakers will walk through several real-world research scenarios that show how different data modalities, including structured tables, narrative notes, imaging and genomics, can be integrated to strengthen cohort design.

This webinar will also address common pitfalls in cohort development, such as diagnostic ambiguity and reliance on single data types.

The speakers will share strategies for working with and validating complex clinical concepts, balancing diagnostic specificity with cohort size and navigating common challenges in real-world data research.

Register to learn more about working with complex multimodal real-world clinical data to support thoughtful, scalable cohort design.

Speakers

Amber Watson, Associate Medical Director, NashBio

Amber Watson is the Associate Medical Director at NashBio, a clinical big data company specializing in real-world clinical, genomic and imaging data to advance the discovery and development of new therapeutics and diagnostics. In her role, Amber supports clinical initiatives that translate complex healthcare data into actionable insights. She partners with stakeholders across research, product and data teams to ensure the clinical integrity of data resources and to guide best practices that enable innovation and client success.

Before joining NashBio, Amber contributed to academic, clinical and healthcare technology settings, supporting research, clinical consulting and scientific communications. She is a Board-Certified Medical Affairs Specialist (BCMAS) and holds a Doctor of Pharmacy (PharmD) degree from the University of Tennessee Health Science Center. Amber is passionate about transforming clinical insights and real-world data into meaningful applications that support better healthcare decision-making.

Message Presenter

Steven Held, Medical Director and VP, Clinical Affairs, NashBio

Steven Held is the Medical Director of NashBio, a for-profit subsidiary of the Vanderbilt University Medical Center (VUMC).  NashBio leverages its real-world clinical and genomic data to advance the discovery and development of new, more personalized therapeutics and diagnostics. Steven oversees the clinical team’s contributions to project delivery and provides clinical input for business development opportunities.

Steven received his Doctor of Medicine degree from the University of South Carolina and a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill. He has over twenty years of post-graduate experience in a variety of practice environments and, more recently, in industry. He is board-certified in internal medicine (ABIM), anatomic pathology (ABP), clinical pathology (ABP) and hematopathology (ABP). He enjoys assisting clients with interpreting and maximizing the power of real-world clinical data.

Message Presenter